Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 19, 2011
Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study
F Tugba Kos, S Aksoy, H Odabas, et al.
Bratislavske Lekarske Listy
|
March 15, 2018
Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma
N S Demirci, N Y Ozdemir, G U Erdem, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 19, 2011
Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated
M Isik, S Caner, M Metin Seker, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 19, 2011
First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab
H Odabas, N Ozdemir, H Abali, et al.
American Journal of Hematology
|
December 10, 1999
The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma
N Zengin, A Kars, A Sungur, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
December 18, 2013
Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients
N Ozdemir, S Aksoy, M A Sendur, et al.
Cancer Investigation
|
January 1, 1996
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas
I Güllü, S Yalçin, G Tekuzman, et al.
Hematology (Amsterdam, Netherlands)
|
July 14, 2016
Comparison of Rai and Binet Classifications in Chronic Lymphocytic Leukemia
N Zengin, A Kars, E Kansu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
September 26, 2013
Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes
T Kos, S Aksoy, M A N Sendur, et al.
Renal Failure
|
March 28, 2013
Evaluation of the renal function using cystatin C level in the patients receiving cisplatin-based chemotherapy
F T Kos, M A N Sendur, S Aksoy, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
October 19, 2011
Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study
F Tugba Kos, S Aksoy, H Odabas, et al.
Bratislavske Lekarske Listy
|
March 15, 2018
Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma
N S Demirci, N Y Ozdemir, G U Erdem, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 19, 2011
Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated
M Isik, S Caner, M Metin Seker, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
July 19, 2011
First-line therapy for metastatic colorectal carcinoma: modified FOLFOX4 or FOLFIRI-bevacizumab
H Odabas, N Ozdemir, H Abali, et al.
American Journal of Hematology
|
December 10, 1999
The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemma
N Zengin, A Kars, A Sungur, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
December 18, 2013
Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients
N Ozdemir, S Aksoy, M A Sendur, et al.
Cancer Investigation
|
January 1, 1996
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas
I Güllü, S Yalçin, G Tekuzman, et al.
Hematology (Amsterdam, Netherlands)
|
July 14, 2016
Comparison of Rai and Binet Classifications in Chronic Lymphocytic Leukemia
N Zengin, A Kars, E Kansu, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
September 26, 2013
Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes
T Kos, S Aksoy, M A N Sendur, et al.
Renal Failure
|
March 28, 2013
Evaluation of the renal function using cystatin C level in the patients receiving cisplatin-based chemotherapy
F T Kos, M A N Sendur, S Aksoy, et al.
Page
of 4